These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 15607965

  • 21. An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency.
    Liu TC, Hallden G, Wang Y, Brooks G, Francis J, Lemoine N, Kirn D.
    Mol Ther; 2004 Jun; 9(6):786-803. PubMed ID: 15194046
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
    Hobom U, Dobbelstein M.
    J Virol; 2004 Jul; 78(14):7685-97. PubMed ID: 15220443
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The human adenovirus E1B-55K oncoprotein coordinates cell transformation through regulation of DNA-bound host transcription factors.
    von Stromberg K, Seddar L, Ip WH, Günther T, Gornott B, Weinert SC, Hüppner M, Bertzbach LD, Dobner T.
    Proc Natl Acad Sci U S A; 2023 Oct 31; 120(44):e2310770120. PubMed ID: 37883435
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53.
    Muller S, Dobner T.
    Cell Cycle; 2008 Mar 15; 7(6):754-8. PubMed ID: 18461721
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL.
    Cancer Res; 2003 Apr 01; 63(7):1490-9. PubMed ID: 12670895
    [Abstract] [Full Text] [Related]

  • 38. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.
    Woo JL, Berk AJ.
    J Virol; 2007 Jan 01; 81(2):575-87. PubMed ID: 17079297
    [Abstract] [Full Text] [Related]

  • 39. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle.
    Goodrum FD, Ornelles DA.
    J Virol; 1997 Jan 01; 71(1):548-61. PubMed ID: 8985383
    [Abstract] [Full Text] [Related]

  • 40. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
    Wimmer P, Berscheminski J, Blanchette P, Groitl P, Branton PE, Hay RT, Dobner T, Schreiner S.
    Oncogene; 2016 Jan 07; 35(1):69-82. PubMed ID: 25772236
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.